CTI BioPharma CEO Adam Craig's 2018 pay falls 46% to $3M
CTI BioPharma reports 2018 executive compensation
By ExecPay News
Published: April 4, 2019
CTI BioPharma reported fiscal year 2018 executive compensation information on April 4, 2019.
In 2018, four executives at CTI BioPharma received on average a compensation package of $1.6M, a 4% increase compared to previous year.
Average pay of disclosed executives at CTI BioPharma
Adam R. Craig, Chief Executive Officer, received $3M in total, which decreased by 46% compared to 2017. 71% of Craig's compensation, or $2.1M, was in option awards. Craig also received $312K in non-equity incentive plan, $564K in salary, as well as $8.3K in other compensation.
Jack W. Singer, Chief Scientific Officer, received a compensation package of $1.3M, which increased by 36% compared to previous year. 59% of the compensation package, or $793K, was in other compensation.
Bruce J. Seeley, Chief Operating Officer, earned $1.1M in 2018, a 22% decrease compared to previous year.
David H. Kirske, Chief Financial Officer, received $884K in 2018, which decreases by 8% compared to 2017.
Related executives
You may also like
Source: SEC filing on April 4, 2019.